Cleidocranial Dysplasia (CCD) is a rare genetic disorder that affects the development of bones and teeth. It is typically diagnosed through a combination of clinical evaluation, medical imaging, and genetic testing.
Clinical Evaluation: The first step in diagnosing CCD involves a thorough clinical evaluation by a healthcare professional, usually a geneticist or a dentist with experience in craniofacial abnormalities. The doctor will review the patient's medical history, conduct a physical examination, and assess the characteristic signs and symptoms associated with CCD.
Medical Imaging: X-rays and other imaging techniques play a crucial role in diagnosing CCD. These imaging studies help visualize the skeletal abnormalities and dental features associated with the condition. The most common findings include:
Genetic Testing: Once the clinical evaluation and imaging studies suggest a diagnosis of CCD, genetic testing is typically performed to confirm the presence of mutations in the RUNX2 gene. This gene is responsible for providing instructions for the production of a protein that plays a crucial role in bone and tooth development. Genetic testing can be done through various methods, including:
It is important to note that while genetic testing can confirm the diagnosis of CCD, it may not be readily available in all healthcare settings. Additionally, genetic testing may not be necessary if the clinical evaluation and imaging studies strongly suggest CCD.
Once a diagnosis of CCD is confirmed, further evaluations and management plans can be developed. These may involve regular dental check-ups, orthodontic treatment, and other interventions to address the specific symptoms and complications associated with CCD.